7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Metabolic and Systemic Heart Diseases
The relationship between metabolic disorders and heart disease is well-established, with conditions like insulin resistance, metabolic syndrome, and obesity playing major roles in the development of cardiovascular diseases. These systemic heart diseases often complicate the management of heart conditions, requiring tailored treatment strategies that address both the metabolic and cardiac aspects. Interventions such as weight management, glucose control, and the use of medications that target metabolic pathways can help reduce the burden of these diseases on the heart. With early detection and proper management, it is possible to prevent the progression of metabolic and systemic heart diseases, ultimately improving patient outcomes and reducing the risk of severe cardiovascular events.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece
Title : Sex-Specific Metabolic Reprogramming by Nanoemulsified Policosanol-Simvastatin Combinations: Synergistic Regulation of the IIS Pathway and BMM-Mediated Lipolysis in a Drosophila Model of Metabolic Syndrome
Lawal Kayode Olatunji, Usmanu Danfodiyo University Sokoto, Nigeria
Title : Intact Right Sinus of Valsalva Aneurysm Dissecting the Interventricular Septum: A Rare Cause of Complete Heart Block in Post-Mitral Valve Replacement
Keval Ajay Shah, APOLLO HOSPITAL NAVI MUMBAI, India